bioMérieux S.A.

Paris Stock Exchange BIM.PA

bioMérieux S.A. Market Capitalization on January 14, 2025: USD 13.08 B

bioMérieux S.A. Market Capitalization is USD 13.08 B on January 14, 2025, a 1.93% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

bioMérieux S.A. 52-week high Market Capitalization is USD 14.39 B on September 12, 2024, which is 10.05% above the current Market Capitalization.
bioMérieux S.A. 52-week low Market Capitalization is USD 11.22 B on June 21, 2024, which is -14.18% below the current Market Capitalization.
bioMérieux S.A. average Market Capitalization for the last 52 weeks is USD 12.79 B.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Paris Stock Exchange: BIM.PA

bioMérieux S.A.

CEO	Mr. Pierre Boulud
IPO Date	July 7, 2004
Location	France
Headquarters	376 Chemin De l'Orme
Employees	13,409
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Key trends

Past 5 years